Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion

Introduction: Continuous subcutaneous insulin infusion (CSII) has been prioritised in the metabolic control of type 1 Diabetes Mellitus (T1DM) in children and adolescents. Objective: To assess the quality of life and treatment satisfaction in adolescents with T1DM using CSII and analyse the role...

Full description

Bibliographic Details
Main Authors: Lígia Lima, Rute Silva, Helena Cardoso, Teresa Martins
Format: Article
Language:English
Published: Instituto Politécnico de Viseu 2022-05-01
Series:Millenium
Subjects:
Online Access:https://revistas.rcaap.pt/millenium/article/view/25955
_version_ 1811239662466891776
author Lígia Lima
Rute Silva
Helena Cardoso
Teresa Martins
author_facet Lígia Lima
Rute Silva
Helena Cardoso
Teresa Martins
author_sort Lígia Lima
collection DOAJ
description Introduction: Continuous subcutaneous insulin infusion (CSII) has been prioritised in the metabolic control of type 1 Diabetes Mellitus (T1DM) in children and adolescents. Objective: To assess the quality of life and treatment satisfaction in adolescents with T1DM using CSII and analyse the role of quality of life in predicting treatment satisfaction among these adolescents. Methods: The sample comprised 77 adolescents aged 10 to 18, followed-up in two central hospitals in the Northern region of Portugal. The Quality-of-Life questionnaire for treatment with Insulin Infusion Pump – adolescents’ version - and the adapted version for adolescents of treatment satisfaction with Insulin Pump questionnaire were used. Results: Most adolescents reported a good quality of life, with lower values in the dimensions related to the Impact of Diabetes, Feelings and Mood and Leisure. They were satisfied with the CSII system, recognizing it as convenient, easy to use and guarantying autonomy. A prediction model was tested through multiple linear regression, with the Impact of diabetes, Leisure Time and Feelings and mood explaining 32.7% of the variance of treatment satisfaction. Conclusion: CSII is a therapeutic option that adolescents with T1DM perceive to promote their quality of life and consider satisfactory, in line with the previous evidence. However, interventions aimed to support these adolescents in managing their disease and treatment should focus on aspects such as self-image and emotional well-being.
first_indexed 2024-04-12T13:05:05Z
format Article
id doaj.art-bcb36fadadf84c468ddf2a126eed25de
institution Directory Open Access Journal
issn 0873-3015
1647-662X
language English
last_indexed 2024-04-12T13:05:05Z
publishDate 2022-05-01
publisher Instituto Politécnico de Viseu
record_format Article
series Millenium
spelling doaj.art-bcb36fadadf84c468ddf2a126eed25de2022-12-22T03:32:04ZengInstituto Politécnico de ViseuMillenium0873-30151647-662X2022-05-0121810.29352/mill0218.25955Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusionLígia Lima0Rute Silva1Helena Cardoso2Teresa Martins3Escola Superior de Enfermagem do Porto, CINTESIS, Porto, PortugalCentro Materno-Infantil do Norte, Porto, PortugalInstituto de Ciências Biomédicas Abel Salazar, Serviço de Endocrinologia Centro Hospitalar e Universitário do Porto, PortugalEscola Superior de Enfermagem do Porto, CINTESIS, Porto, Portugal Introduction: Continuous subcutaneous insulin infusion (CSII) has been prioritised in the metabolic control of type 1 Diabetes Mellitus (T1DM) in children and adolescents. Objective: To assess the quality of life and treatment satisfaction in adolescents with T1DM using CSII and analyse the role of quality of life in predicting treatment satisfaction among these adolescents. Methods: The sample comprised 77 adolescents aged 10 to 18, followed-up in two central hospitals in the Northern region of Portugal. The Quality-of-Life questionnaire for treatment with Insulin Infusion Pump – adolescents’ version - and the adapted version for adolescents of treatment satisfaction with Insulin Pump questionnaire were used. Results: Most adolescents reported a good quality of life, with lower values in the dimensions related to the Impact of Diabetes, Feelings and Mood and Leisure. They were satisfied with the CSII system, recognizing it as convenient, easy to use and guarantying autonomy. A prediction model was tested through multiple linear regression, with the Impact of diabetes, Leisure Time and Feelings and mood explaining 32.7% of the variance of treatment satisfaction. Conclusion: CSII is a therapeutic option that adolescents with T1DM perceive to promote their quality of life and consider satisfactory, in line with the previous evidence. However, interventions aimed to support these adolescents in managing their disease and treatment should focus on aspects such as self-image and emotional well-being. https://revistas.rcaap.pt/millenium/article/view/25955type 1 diabetesadolescentsquality of lifepatient satisfaction
spellingShingle Lígia Lima
Rute Silva
Helena Cardoso
Teresa Martins
Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
Millenium
type 1 diabetes
adolescents
quality of life
patient satisfaction
title Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_full Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_fullStr Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_full_unstemmed Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_short Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_sort treatment satisfaction and quality of life of adolescents with t1dm using continuous subcutaneous insulin infusion
topic type 1 diabetes
adolescents
quality of life
patient satisfaction
url https://revistas.rcaap.pt/millenium/article/view/25955
work_keys_str_mv AT ligialima treatmentsatisfactionandqualityoflifeofadolescentswitht1dmusingcontinuoussubcutaneousinsulininfusion
AT rutesilva treatmentsatisfactionandqualityoflifeofadolescentswitht1dmusingcontinuoussubcutaneousinsulininfusion
AT helenacardoso treatmentsatisfactionandqualityoflifeofadolescentswitht1dmusingcontinuoussubcutaneousinsulininfusion
AT teresamartins treatmentsatisfactionandqualityoflifeofadolescentswitht1dmusingcontinuoussubcutaneousinsulininfusion